Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Vienna General Hospital · Austrian Breast & Colorectal Cancer Study Group · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
876
total citations
- FWCI
- 69.11
- Percentile
- 100%
- References
- 38
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Anastrozole
- Tamoxifen
- Medicine
- Breast cancer
- Aromatase inhibitor
- Oncology
- Internal medicine
- Hazard ratio
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.